Resources with keywords: vaccines
What to know about booster shots and third doses of the COVID-19 vaccine (NEW 10/6, Website)
University of Chicago Medicine
15 August 2021
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 (NEW 8/18, Website, Publication)
CDC/MMWR
13 August 2021
ARCHIVED: Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 (Website, Publication)
CDC/MMWR
13 August 2021
ARCHIVED: Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021 (Website, Publication)
CDC/MMWR
13 August 2021
COVID Data Tracker Weekly Review (Archived) (Website, Regulatory)
CDC Archive
May 11, 2023, marked the end of the federal COVID-19 public health emergency (PHE) declaration. This doesn’t mean that COVID-19 is over, but the end of the PHE did initiate a cascade of updates to COVID-19 data collection, reporting, and surveillance. Some surveillance metrics will remain the same, but some will change in terms of reporting frequency, data sources, or availability.
Pfizer Vaccine’s Protection Still Strong After 6 Months (NEW 8/3, Document, News)
Wall Street Journal (WSJ)
29 July 2021
ARCHIVED: BioNTech CEO Not Sure About Third Vaccine Dose (Document, News)
Wall Street Journal (WSJ)
26 July 2021
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses (NEW 8/3, Website, Publication)
JAMA
23 July 2021
Ilies Benotmane, Gabriela Gautier, Peggy Perrin, et al
